Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Küpfer

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Electrophoresis|January 1, 1994
Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in manC Desiderio, S Fanali, A Küpfer, et al.
Journal of Chromatography|October 8, 1982
Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatographyA Küpfer, R James, K Carr, et al.
European Journal of Clinical Pharmacology|August 22, 2000
Pharmacokinetics and organ distribution of intravenous and oral methylene blueC Peter, D Hongwan, A Küpfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patientsT Cerny, A Küpfer, T Zeugin, et al.
Nucleic Acids Research|October 13, 2007
Trans-lesion synthesis and RNaseH activity by reverse transcriptases on a true abasic RNA templatePascal A Küpfer, Caroline Crey-Desbiolles, Christian J Leumann
Schweizerische Medizinische Wochenschrift|August 26, 1989
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration]B Roth, T Cerny, K W Brunner, et al.
Epilepsia|July 1, 1986
Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patientsB F Bourgeois, A Küpfer, N Wad, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarateH Saner, H P Gurtner, R Preisig, et al.
Journal of Neurology|April 1, 1986
Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluationC W Hess, T Hunziker, A Küpfer, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Increased urinary losses of carnitine during ifosfamide chemotherapyN P Marthaler, T Visarius, A Küpfer, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Electrophoresis|January 1, 1994
Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in manC Desiderio, S Fanali, A Küpfer, et al.
Journal of Chromatography|October 8, 1982
Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatographyA Küpfer, R James, K Carr, et al.
European Journal of Clinical Pharmacology|August 22, 2000
Pharmacokinetics and organ distribution of intravenous and oral methylene blueC Peter, D Hongwan, A Küpfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patientsT Cerny, A Küpfer, T Zeugin, et al.
Nucleic Acids Research|October 13, 2007
Trans-lesion synthesis and RNaseH activity by reverse transcriptases on a true abasic RNA templatePascal A Küpfer, Caroline Crey-Desbiolles, Christian J Leumann
Schweizerische Medizinische Wochenschrift|August 26, 1989
[Urinary bioavailability of sodium-2-mercaptoethanesulfonate (Uromitexan) following intravenous, subcutaneous and continuous subcutaneous administration]B Roth, T Cerny, K W Brunner, et al.
Epilepsia|July 1, 1986
Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patientsB F Bourgeois, A Küpfer, N Wad, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarateH Saner, H P Gurtner, R Preisig, et al.
Journal of Neurology|April 1, 1986
Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluationC W Hess, T Hunziker, A Küpfer, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Increased urinary losses of carnitine during ifosfamide chemotherapyN P Marthaler, T Visarius, A Küpfer, et al.
Pageof 6